AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 APR 3 - (NewsRx.com & NewsRx.net) -- New technologies have improved the ability to diagnose and excise breast cancer.
According to a study from the United States, "Until recently little advance in the diagnosis and excision of breast cancer has been made since the inception of needle localization breast biopsy (NLBB)."
"Stereotactic core needle breast biopsy (SCNBB) can avoid most NLBB especially for calcifications. However, when open biopsy is necessary NLBB has been the standard of care. As many as 50% of nonpalpable lesions can be seen by ultrasound (US) to avoid the unpleasantness and complications associated with NLBB," stated V.S. Klimberg and coauthors, University of Arkansas Medical Sciences, Department of Surgery.
"Further, SCNBB leaves a blood-filled cavity that can be easily seen by US. Intraoperative US can be used to direct the excision while improving margin negativity. MRI has improved sensitivity in detecting suspicious breast lesions and techniques such as hematoma-directed US-guided breast ...